Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx181 AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting Full Text Astellas, May 17, 2013
182 Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference Full Text Bristol Myers-Squibb, May 17, 2013
183 Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting Full Text Bristol Myers-Squibb, May 17, 2013
184 Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights Full Text Bristol Myers-Squibb, May 17, 2013
185 Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation Full Text Bristol Myers-Squibb, May 17, 2013
186 Bristol-Myers Squibb to Present at UBS Global Health Care Conference Full Text Bristol Myers-Squibb, May 17, 2013
187 Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock Full Text Bristol Myers-Squibb, May 17, 2013
188 Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period Full Text Bristol Myers-Squibb, May 17, 2013
189 JAPhA Releases Special Features on Minnesotas Statewide MTM Programs Full Text American Pharmacists Association News, May 17, 2013
190 NYeC Announces Statewide Patient Portal Design Challenge Winners Full Text Healthcare Informatics, May 17, 2013
191 JAPhA Releases Study About Drug and Dietary Supplement by NCAA College Athletes Full Text American Pharmacists Association News, May 17, 2013
192 Rotavirus vaccine developed in India shows positive results Full Text American Pharmacists Association News, May 17, 2013
193 Pfizer launches website for purchasing Viagra safely Full Text American Pharmacists Association News, May 17, 2013
194 Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys The Lancet, May 17, 2013 Evidence Based Medicine Clinical Article
195 FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer Full Text Roche, May 16, 2013
196 Merck Prices $ 6.5 Billion Debt Offering Full Text Merck, May 16, 2013
197 Kaiser Permanente Northwest Joins the Oregon Health Network Full Text Healthcare Informatics, May 16, 2013
198 Allscripts Earnings Report Shows Continued Slump Full Text Healthcare Informatics, May 16, 2013
199 Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors Full Text Valeant Pharmaceuticals International, May 16, 2013
200 MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems Imaging Economics, May 16, 2013 Review Article
1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013 Free full text
2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013 Free full text
3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013 Free full text
4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013 Free full text
5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013 Free full text
6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013 Free full text
7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013 Free full text
8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013 Free full text
9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013 Free full text
10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013 Free full text
11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013 Free full text
12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013 Free full text
13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013 Free full text
14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013 Free full text
15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013 Free full text
16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013 Free full text
17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013 Free full text
18 Astellas pharma us, inc. names new president Astellas, April 3, 2013 Free full text
19 Medivation and astellas provide update on prevail Astellas, April 5, 2013 Free full text
20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close